These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2181004)

  • 1. Virology, immunology, and clinical course of HIV infection.
    McCutchan JA
    J Consult Clin Psychol; 1990 Feb; 58(1):5-12. PubMed ID: 2181004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed activation of T-lymphocytes. A theoretical basis for short term treatment of AIDS with azidothymidine.
    Forsdyke DR
    Med Hypotheses; 1991 Jan; 34(1):24-7. PubMed ID: 2056923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis, natural history, and classification of HIV infection.
    Libman H
    Prim Care; 1992 Mar; 19(1):1-17. PubMed ID: 1594691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunology of HIV infection.
    Zunich KM; Lane HC
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1202-5. PubMed ID: 2141867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune system in AIDS.
    Laurence J
    Sci Am; 1985 Dec; 253(6):84-93. PubMed ID: 2999972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does HIV cause AIDS?
    Weiss RA
    Science; 1993 May; 260(5112):1273-9. PubMed ID: 8493571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
    Longini IM; Clark WS; Karon JM
    Am J Epidemiol; 1993 Jun; 137(11):1229-40. PubMed ID: 8100682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral strategies in the replication of human immunodeficiency virus].
    Wainberg MA; Bour S; Geleziunas R; Bentwich Z
    Union Med Can; 1992; 121(5):307-9, 312-4. PubMed ID: 1279875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS: immunologic abnormalities following human immunodeficiency virus infection.
    Batra P
    J Thorac Imaging; 1991 Sep; 6(4):1-5. PubMed ID: 1942190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling HIV concentration during acute AIDS infection.
    Wilson SE; Habeshaw JA; Oxford JS
    Science; 1996 Jun; 272(5270):1960-2. PubMed ID: 8658173
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population dynamics of HIV within an individual after treatment with zidovudine.
    McLean AR; Emery VC; Webster A; Griffiths PD
    AIDS; 1991 May; 5(5):485-9. PubMed ID: 1677807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of lung infections associated with human immunodeficiency virus infection.
    Hopewell PC
    Thorax; 1989 Dec; 44(12):1038-44. PubMed ID: 2575801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunology and virology of HIV infection: current concepts in the pathogenesis of AIDS].
    Miedema F; Tersmette M; Roos MT; Schellekens PT
    Ned Tijdschr Geneeskd; 1990 Sep; 134(36):1724-8. PubMed ID: 2215725
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
    Lu W; Shih JW; Tourani JM; Eme D; Alter HJ; Andrieu JM
    AIDS; 1993 Nov; 7 Suppl 2():S91-9. PubMed ID: 7909232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection.
    Gerna G; Parea M; Percivalle E; Zipeto D; Silini E; Barbarini G; Milanesi G
    AIDS; 1990 Oct; 4(10):1027-31. PubMed ID: 2175616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH conference. Antiretroviral therapy in AIDS.
    Broder S; Mitsuya H; Yarchoan R; Pavlakis GN
    Ann Intern Med; 1990 Oct; 113(8):604-18. PubMed ID: 1698042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.